Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

1.

Combination immunotherapy for tumors via sequential intratumoral injections of oncolytic herpes simplex virus 1 and immature dendritic cells.

Farrell CJ, Zaupa C, Barnard Z, Maley J, Martuza RL, Rabkin SD, Curry WT Jr.

Clin Cancer Res. 2008 Dec 1;14(23):7711-6. doi: 10.1158/1078-0432.CCR-08-1364.

PMID:
19047097
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Expression of FMS-like tyrosine kinase 3 ligand by oncolytic herpes simplex virus type I prolongs survival in mice bearing established syngeneic intracranial malignant glioma.

Barnard Z, Wakimoto H, Zaupa C, Patel AP, Klehm J, Martuza RL, Rabkin SD, Curry WT Jr.

Neurosurgery. 2012 Sep;71(3):741-8; discussion 748. doi: 10.1227/NEU.0b013e318260fd73.

PMID:
22653387
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells.

Kanai R, Rabkin SD, Yip S, Sgubin D, Zaupa CM, Hirose Y, Louis DN, Wakimoto H, Martuza RL.

J Natl Cancer Inst. 2012 Jan 4;104(1):42-55. doi: 10.1093/jnci/djr509. Epub 2011 Dec 15.

PMID:
22173583
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Tumor infection by oncolytic reovirus primes adaptive antitumor immunity.

Prestwich RJ, Errington F, Ilett EJ, Morgan RS, Scott KJ, Kottke T, Thompson J, Morrison EE, Harrington KJ, Pandha HS, Selby PJ, Vile RG, Melcher AA.

Clin Cancer Res. 2008 Nov 15;14(22):7358-66. doi: 10.1158/1078-0432.CCR-08-0831.

PMID:
19010851
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Enhanced antitumor efficacy of low-dose Etoposide with oncolytic herpes simplex virus in human glioblastoma stem cell xenografts.

Cheema TA, Kanai R, Kim GW, Wakimoto H, Passer B, Rabkin SD, Martuza RL.

Clin Cancer Res. 2011 Dec 1;17(23):7383-93. doi: 10.1158/1078-0432.CCR-11-1762. Epub 2011 Oct 5.

PMID:
21976549
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

HSV-NIS, an oncolytic herpes simplex virus type 1 encoding human sodium iodide symporter for preclinical prostate cancer radiovirotherapy.

Li H, Nakashima H, Decklever TD, Nace RA, Russell SJ.

Cancer Gene Ther. 2013 Aug;20(8):478-85. doi: 10.1038/cgt.2013.43. Epub 2013 Jul 19.

PMID:
23868101
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

An oncolytic herpes simplex virus vector, G47Δ, synergizes with paclitaxel in the treatment of breast cancer.

Zeng WG, Li JJ, Hu P, Lei L, Wang JN, Liu RB.

Oncol Rep. 2013 Jun;29(6):2355-61. doi: 10.3892/or.2013.2359. Epub 2013 Mar 22.

PMID:
23525624
[PubMed - indexed for MEDLINE]
8.

Virotherapy with a type 2 herpes simplex virus-derived oncolytic virus induces potent antitumor immunity against neuroblastoma.

Li H, Dutuor A, Tao L, Fu X, Zhang X.

Clin Cancer Res. 2007 Jan 1;13(1):316-22.

PMID:
17200370
[PubMed - indexed for MEDLINE]
Free Article
9.

Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV.

Yoo JY, Pradarelli J, Haseley A, Wojton J, Kaka A, Bratasz A, Alvarez-Breckenridge CA, Yu JG, Powell K, Mazar AP, Teknos TN, Chiocca EA, Glorioso JC, Old M, Kaur B.

Clin Cancer Res. 2012 Sep 15;18(18):4931-41. Epub 2012 Jul 2.

PMID:
22753591
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Herpes simplex virus delivery to orthotopic rectal carcinoma results in an efficient and selective antitumor effect.

Kolodkin-Gal D, Edden Y, Hartshtark Z, Ilan L, Khalaileh A, Pikarsky AJ, Pikarsky E, Rabkin SD, Panet A, Zamir G.

Gene Ther. 2009 Jul;16(7):905-15. doi: 10.1038/gt.2009.44. Epub 2009 May 14.

PMID:
19440231
[PubMed - indexed for MEDLINE]
11.

Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors.

Wakimoto H, Kesari S, Farrell CJ, Curry WT Jr, Zaupa C, Aghi M, Kuroda T, Stemmer-Rachamimov A, Shah K, Liu TC, Jeyaretna DS, Debasitis J, Pruszak J, Martuza RL, Rabkin SD.

Cancer Res. 2009 Apr 15;69(8):3472-81. doi: 10.1158/0008-5472.CAN-08-3886. Epub 2009 Apr 7.

PMID:
19351838
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Oncolytic virus therapy using genetically engineered herpes simplex viruses.

Todo T.

Front Biosci. 2008 Jan 1;13:2060-4. Review.

PMID:
17981691
[PubMed - indexed for MEDLINE]
13.

Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers.

Varghese S, Rabkin SD, Liu R, Nielsen PG, Ipe T, Martuza RL.

Cancer Gene Ther. 2006 Mar;13(3):253-65.

PMID:
16179929
[PubMed - indexed for MEDLINE]
14.

CTLA-4 blockade enhances antitumor immunity of intratumoral injection of immature dendritic cells into irradiated tumor in a mouse colon cancer model.

Son CH, Bae JH, Shin DY, Lee HR, Choi YJ, Jo WS, Ho Jung M, Kang CD, Yang K, Park YS.

J Immunother. 2014 Jan;37(1):1-7. doi: 10.1097/CJI.0000000000000007.

PMID:
24316550
[PubMed - indexed for MEDLINE]
15.
16.

Oncolytic herpes simplex virus treatment of metastatic breast cancer.

Wang J, Hu P, Zeng M, Rabkin SD, Liu R.

Int J Oncol. 2012 Mar;40(3):757-63. doi: 10.3892/ijo.2011.1266. Epub 2011 Nov 21.

PMID:
22108767
[PubMed - indexed for MEDLINE]
17.

Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.

Choi KJ, Kim JH, Lee YS, Kim J, Suh BS, Kim H, Cho S, Sohn JH, Kim GE, Yun CO.

Gene Ther. 2006 Jul;13(13):1010-20. Epub 2006 Mar 9.

PMID:
16525479
[PubMed - indexed for MEDLINE]
18.

Molecular engineering and validation of an oncolytic herpes simplex virus type 1 transcriptionally targeted to midkine-positive tumors.

Maldonado AR, Klanke C, Jegga AG, Aronow BJ, Mahller YY, Cripe TP, Crombleholme TM.

J Gene Med. 2010 Jul;12(7):613-23. doi: 10.1002/jgm.1479.

PMID:
20603890
[PubMed - indexed for MEDLINE]
19.

Local and distant immune-mediated control of colon cancer growth with fusogenic membrane glycoproteins in combination with viral oncolysis.

Hoffmann D, Bayer W, Wildner O.

Hum Gene Ther. 2007 May;18(5):435-50.

PMID:
17518612
[PubMed - indexed for MEDLINE]
20.

Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer.

Castelo-Branco P, Passer BJ, Buhrman JS, Antoszczyk S, Marinelli M, Zaupa C, Rabkin SD, Martuza RL.

Gene Ther. 2010 Jun;17(6):805-10. doi: 10.1038/gt.2010.20. Epub 2010 Mar 11.

PMID:
20220784
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk